BIO Investigación vasca en salud
Centro
Swansea University
Swansea, Reino UnidoPublicaciones en colaboración con investigadores/as de Swansea University (24)
2023
-
Causes of death in children with congenital anomalies up to age 10 in eight European countries
BMJ Paediatrics Open, Vol. 7, Núm. 1
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomalies
BMJ Open, Vol. 13, Núm. 7
2022
-
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
European Urology Focus, Vol. 8, Núm. 6, pp. 1673-1682
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Temporal and geographical variations in survival of children born with congenital anomalies in Europe: A multi-registry cohort study
Paediatric and Perinatal Epidemiology, Vol. 36, Núm. 6, pp. 792-803
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
2019
2017
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
-
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2012
-
Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2129-2143
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196
2006
-
Social stress, coping strategies and tumor development in male mice: Behavioral, neuroendocrine and immunological implications
Psychoneuroendocrinology, Vol. 31, Núm. 1, pp. 69-79
2005
-
Time-dependent behavioral, neurochemical, and immune consequences of repeated experiences of social defeat stress in male mice and the ameliorative effects of fluoxetine
Brain, Behavior, and Immunity, Vol. 19, Núm. 6, pp. 530-539